Use of a standardized uptake value for parametric in vivo imaging of benzodiazepine receptor distribution on [11C]flumazenil brain PET

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 6, 2004, Pages 846-851

  Tsukamoto, Masahito ^a   Katoh, Chietsugu ^a   Shiga, Tohru ^a   Kaji, Tomohito ^a   Kuge, Yuji ^a   Nakada, Kunihiro ^a   Tamaki, Nagara ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Benzodiazepine; Cerebrovascular diseases; Distribution volume image; SUV image; 11C flumazenil PET

Indexed keywords

BENZODIAZEPINE RECEPTOR; CARBON 11; FLUMAZENIL;

ADULT; ARTICLE; BRAIN; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISTRIBUTION VOLUME; DRUG UPTAKE; EPILEPSY; FEMALE; HUMAN; MALE; NERVE CELL; POSITRON EMISSION TOMOGRAPHY; RECEPTOR AFFINITY; RECEPTOR DENSITY;

EID: 2942525222     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1458-4     Document Type: Article

References (39)

1. Heiss WD, Graf R, Fujita T, Ohta K, Bauer B, Lottgen J, Wienhard K. Early detection of irreversibly damaged ischemic tissue by flumazenil positron emission tomography in cats. Stroke 1997; 28:2045-2051; discussion 2051-2052.
2. Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, Bauer B, Wienhard K. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke 1998; 29:454-461.
3. 2O positron emission tomography predicts irreversible ischemic cortical damage in stroke patients receiving acute thrombolytic therapy. Stroke 2000; 31:366-369.
4. Heiss WD, Kracht LW, Thiel A, Grond M, Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain 2001; 124:20-29.
5. 18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry 1993; 56:615-621.
6. Savic I, Pauli S, Thorell JO, Blomqvist G. In vivo demonstration of altered benzodiazepine receptor density in patients with generalised epilepsy. J Neurol Neurosurg Psychiatry 1994; 57:797-804.
7. 11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 1995; 36:1225-1232.
8. Savic I, Svanborg E, Thorell JO. Cortical benzodiazepine receptor changes are related to frequency of partial seizures: a positron emission tomography study. Epilepsia 1996; 37:236-244.
9. 11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand 1998; 97:279-286.
10. Szelies B, Weber-Luxenburger G, Pawlik G, Kessler J, Holthoff V, Mielke R, Herholz K, Bauer B, Wienhard K, Heiss WD. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy. Neuroimage 1996; 3:109-118.
11. Szelies B, Weber-Luxenburger G, Mielke R, Pawlik G, Kessler J, Pietrzyk U, Bauer B, Heiss WD. Interictal hippocampal benzodiazepine receptors in temporal lobe epilepsy: comparison with coregistered hippocampal metabolism and volumetry. Eur J Neurol. 2000; 7:393-400.
12. 11C-flumazenil PET. Eur J Neurol 2002; 9:137-142.
13. Hammers A, Koepp MJ, Richardson MP, Labbe C, Brooks DJ, Cunningham VJ, Duncan JS. Central benzodiazepine receptors in malformations of cortical development: a quantitative study. Brain 2001; 124:1555-1565.
14. 11C-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001; 56:897-906.
15. 11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain 2002; 125:2257-2271.
16. Hammers A, Koepp MJ, Richardson MP, Hurlemann R, Brooks DJ, Duncan JS. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients. Brain 2003; 126:1300-1318.
17. 11C- flumazenil PET study. Ann Neurol 1996; 40:188-198.
18. 11C-flumazenil PET in neocortical epilepsy. Neurology 1998; 51:485-492.
19. A receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study. Epilepsia 2001; 42:1327-1334.
20. 11C-flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology 1997; 49:764-773.
21. 11C]flumazenil positron emission tomography study. Epilepsia 1997; 38:1089-1097.
22. 11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain 1997; 120:1865-1876.
23. 3H]flumazenil autoradiography in hippocampal sclerosis, Ann Neurol. 1998; 43:618-626.
24. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000; 54:332-339.
25. Macdonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology 1997; 26:277-282.
26. Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, St Laurent RT. Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography. Ann Neurol 1995; 38:176-185.
27. Gilman S, Koeppe RA, Adams K, Johnson-Greene D, Junck L, Kluin KJ, Brunberg J, Martorello S, Lohman M. Positron emission tomographic studies of cerebral benzodiazepine-receptor binding in chronic alcoholics. Ann Neurol 1996; 40:163-171.
28. A-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998; 55:715-720.
29. Holthoff VA, Koeppe RA, Frey KA, Penney JB, Markel DS, Kuhl DE, Young AB. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Ann Neurol 1993; 34:76-81.
30. Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Arch Neurol 1995; 52:314-317.
31. Ohyama M, Senda M, Ishiwata K, Kitamura S, Mishina M, Ishii K, Toyama H, Oda K, Katayama Y. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 1999; 13:309-315.
32. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991; 11:735-744.
33. Abadie P, Baron JC, Bisserbe JC, Boulenger JP, Rioux P, Travere JM, Barre L, Petit-Taboue MC, Zarifian E. Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. Eur J Pharmacol 1992; 213:107-115.
34. 11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans. Int J Rad Appl Instrum [A] 1991; 42:435-439.
35. Delforge J, Millet P, Bendriem B, Cinotti L, Samson Y, Syrota A. Equivalence between the delayed PET activity and the distribution volume for the ligand verifying the double equilibrium property. J Cereb Blood Flow Metab 1995; 15: Suppl 640.
36. Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Ann Neurol 1991; 30:663-672.
37. Millet P, Delforge J, Mauguiere F, Pappata S, Cinotti L, Frouin V, Samson Y, Bendriem B, Syrota A. Parameter and index images of benzodiazepine receptor concentration in the brain. J Nucl Med 1995; 36:1462-1471.
38. 11C] flumazenil PET. Ann Nucl Med 2000; 14:193-198.
39. Sekino H, Nakamichi N, Kamimura H, Yanai K, Watanabe T, Higuchi S, Ueki M. Phase I study of YM 684 (flumazenil). Igaku to Yakugaku 1990; 23:777-796.